Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
This grant opportunity is designed to support the development of new medications to prevent and treat substance use disorders (SUDs) and overdose. It involves a two-phase process. The first phase (UG3) provides funding for two years to projects that have specific milestones. If these milestones are successfully met, the project can transition to the second phase (UH3), which offers three more …
The purpose of this Notice of Funding Opportunity (NOFO) is to support the discovery and development of medications to prevent and treat substance use disorders (SUDs) and overdose. The UG3/UH3 Phase Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project wit…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers